Qing Li
Shanghai Cancer Institute(CN)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Cancer, Hypoxia, and Metabolism, Hippo pathway signaling and YAP/TAZ, Cancer-related molecular mechanisms research, RNA modifications and cancer
Most-Cited Works
- → Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases(2018)1,297 cited
- → Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway(2018)508 cited
- → Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway(2001)360 cited
- → Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K/AKT/GSK3β/β-catenin pathway(2019)315 cited
- → Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice(2017)284 cited
- → Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma(2020)170 cited
- → SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin–Rho GTPase–Hippo Pathways(2018)156 cited
- → Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis(2021)144 cited
- → Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis(2018)141 cited
- → Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma(2023)129 cited